Drug Search Results
More Filters [+]

AV-0328

Alternative Names: av-0328, av0328, av 0328
Latest Update: 2024-09-10
Latest Update Note: News Article

Product Description

It was found to induce antibodies capable of killing a wide range of PNAG-expressing pathogens.

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Alopexx
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AV-0328

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Pneumonia|Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AV-101-16

P2

Completed

Pneumonia|Influenza, Human

2018-04-23

26%

Recent News Events